For the year ending 2025-12-31, AVIR has $315,218K in assets. $39,784K in debts. $95,713K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 95,713 | |||
| Marketable securities | 206,117 | |||
| Prepaid expenses and other current assets | 9,161 | |||
| Total current assets | 310,991 | |||
| Total property and equipment, at cost | 1,978 | |||
| Less accumulated depreciation and amortization | 1,521 | |||
| Property and equipment, net | 457 | |||
| Other assets | 3,136 | |||
| Operating lease right-of-use assets, net | 634 | |||
| Total assets | 315,218 | |||
| Accounts payable | 12,945 | |||
| Accrued expenses and other current liabilities | 25,996 | |||
| Current portion of operating lease liabilities | 843 | |||
| Total current liabilities | 39,784 | |||
| Operating lease liabilities | 0 | |||
| Income taxes payable | 0 | |||
| Total liabilities | 39,784 | |||
| Common stock, 0.001 par value 300,000,000 shares authorized 78,126,796 and 84,463,059 shares issued and outstanding as of december 31, 2025 and 2024 | 78 | |||
| Additional paid-in capital | 797,751 | |||
| Accumulated other comprehensive gain | 174 | |||
| Accumulated deficit | -522,569 | |||
| Total stockholders equity | 275,434 | |||
| Total liabilities and stockholders equity | 315,218 | |||
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)